Dr. Eunice Wang appointed to oversee pivotal aspect of cancer care
- Infusion is direct administration of chemotherapy or other medication into blood
- Dr. Wang will oversee program on main campus and satellite centers
- A fellowship-trained hematology expert, she remains Chief of Leukemia
BUFFALO, N.Y. — Infusions of chemotherapy or other medications: They’re facets of oncology that often make up a big portion of a patient’s cancer care. It’s treatment that can take up many hours in a clinic or in an inpatient setting, delivered by dedicated oncology nurses and physicians. At Roswell Park Comprehensive Cancer Center, that dedication is seen day in and day out by veteran staff member Eunice Wang, MD, who has been selected to lead this team as the newly appointed Medical Director of Infusion Services.
At Roswell Park’s Chemotherapy and Infusion Centers, patients get treatment regimens delivered directly into to their bloodstream. As Medical Director, Dr. Wang will oversee infusion services on the main campus and at Roswell Park’s satellite clinics, focused on a patient-centric approach to care and treatment plans.
Dr. Wang has served in multiple roles since joining Roswell Park in 2003, including Co-Chair of the Leukemia Translational Research Group and Physician Leader with the Chemotherapy and Infusion Center. She will continue in her role as Chief of Leukemia.
Most recently, Dr. Wang has proved pivotal in disseminating vital information about patient care and safety at Roswell Park during the COVID-19 pandemic, having appeared on a live chat for patients, a webinar for physicians and a 30-minute television special.
“Dr. Wang is a fierce and attentive patient advocate, which makes her the ideal person to lead Infusion Services,” says Candace S. Johnson, PhD, President & CEO and M&T Bank Presidential Chair in Leadership at Roswell Park. “Her passion for outstanding care will be a guiding force for this important clinical program.”
Dr. Wang earned her medical degree from the Keck School of Medicine, University of Southern California, and completed residency training in internal medicine at Yale-New Haven Hospital, Yale University. She completed a clinical hematology-oncology and research fellowship at Memorial Sloan Kettering Cancer Center. Her research focuses on the development of early-stage clinical trials for acute leukemias (AML, ALL) and myeloproliferative disorders.
Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.
Rebecca Vogt, Media Relations Specialist